# Pilot Study DiaDEP

> **NCT03912012** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 23 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Type1diabetes

## Interventions

- **DRUG:** Iohexol renal clearance measurement
- **DEVICE:** microcirculation assessment through Laser Doppler associated to iontophoresis.
- **DEVICE:** Cardiovascular assessment though Intima-media Thickness and Extra-media Thickness measurement
- **BIOLOGICAL:** Blood sampling
- **BIOLOGICAL:** Urine sampling
- **DEVICE:** High-resolution peripheral quantitative computed tomography (HR-pQCT)
- **RADIATION:** Dual-energy X-ray (DXA)

## Key facts

- **NCT ID:** NCT03912012
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-09
- **Primary completion:** 2020-11-20
- **Final completion:** 2020-11-20
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03912012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03912012, "Pilot Study DiaDEP". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03912012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*